期刊文献+

基于醋酸钙pH值梯度法制备抗耐药结核菌的环丝氨酸脂质体实验研究

The study on the preparation of anti-TB cycloserine liposome by pH gradient method
下载PDF
导出
摘要 目的选取制备环丝氨酸脂质体的最佳条件。方法以pH梯度法制备环丝氨酸脂质体,采用透析法分离脂质体和游离环丝氨酸后通过包封率的计算考察最佳制备条件。结果通过正交设计实验分析得出最佳制备工艺条件为EggPC与Ch的摩尔比为4∶1,醋酸钙浓度为0.2 mol/L,环丝氨酸与EggPC的质量比1∶4。结论本研究制备的环丝氨酸脂质体包封率较高,对环丝氨酸脂质体的肺部给药提供重要基础。 Objective To prepare anti-TB cycloserine liposome by pH gradient method and establish the optimal condition.Methods To prepare the cycloserine liposome by the pH gradient method and separate the lipsome and the drug by dialysis method establish the optimal condition through the investigation of the encapsulation rate.Results The condition from orthogonal design experiment is EggPC∶Ch=4∶1the Ca(AC)2concentration0.2mol/L ring serine:EggPC=1∶4.Conclusion the encapsulation rate of lipsome is high this study provide the foundation for further research of pulmonary drug delivery.
作者 李广涛 杜鹏 刘金丽 刘世娟 李华阳 崔新宇 佟雷 LI Guang-tao;DU Peng;Liu Jin-li;LIU Shi-juan;LI Huayang;CUI Xin-yu;TONG Lei(Mudanjiang medical university;mudanjiang kangan hospital;mudanjiang medical university, hongqi hospital,Heilongjiang province Mudanjiang 157011, China)
出处 《中国处方药》 2017年第3期23-24,共2页 Journal of China Prescription Drug
基金 黑龙江省卫生计生委科研课题(2016-369) 牡丹江市科学技术计划项目(Z2015s0063) 牡丹江市科学技术计划项目(Z2015s0037)
关键词 pH值梯度法 环丝氨酸脂质体 耐药结核菌 pH gradient Cycloserine liposome Extensively drug-resistant tuberculosis
  • 相关文献

参考文献3

二级参考文献23

  • 1熊非,朱家壁,王维,华小兵.灯盏花素纳米脂质体包封率测定方法研究[J].药学学报,2004,39(9):755-757. 被引量:33
  • 2王健松,朱家壁,吕瑞勤,沈伟.肺靶向阿奇霉素脂质体的制备及其在小鼠体内的分布[J].药学学报,2005,40(3):274-278. 被引量:30
  • 3Huang YY, Wang CH. Pulmonary delivery of insulin by liposomal carriers[J]. J Controlled Release, 2006, 113 (1): 9- 14.
  • 4Zam M, Mourtas S, Klepetsanis Pet al. Liposomes for drug delivery to the lungs by nebulization[J]. Eur J Pharm Biopharm, 2007, 67(3): 655- 6.
  • 5Mitra R, Pezron I, Li Y, et al. Enhanced pulmonary dehvery of insulin by lung lavage fluid and phospholipids[J]. Int J Pharm, 2001, 217(1-2): 25- 31.
  • 6Hajos F, Stark B, Hensler S, et al. Inhalable liposomal formulation for vasoactive intestinal peptide[J]. Int J Pharm, 2008, 357 (1-2): 286-94.
  • 7Shoyele SA, Slowey A. Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery [J]. Int J Pharm, 2006, 314(1): 1-8.
  • 8Vyas SP, Kannan ME, Jain SY, et al. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophage[J]. Int J Pharm, 2004, 269 (1): 37 - 49.
  • 9Le J, Schiller DS. Aerosolized Delivery of Antifungal Agents[J]. Curr Fungal Infect Rep, 2010, 4(2): 96-102.
  • 10Vyas SP, Quraishi S, Gupta S, et al.Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages[J]. Int J Pharm, 2005, 296(1-2): 12- 25.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部